They don't grow, don't manufacture and don't prescribe anything. Let's face it - they are more about optics and public perception than revenue generation.
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game